Safety and biodistribution evaluation in CNGB3-deficient mice of rAAV2tYF-PR1. 7-hCNGB3, a recombinant AAV vector for treatment of achromatopsia

G Ye, E Budzynski, P Sonnentag, TM Nork… - Human Gene …, 2016 - liebertpub.com
Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1. 7-
hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human …
被引用次数：31 相关文章

Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1. 7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.

GJ Ye, E Budzynski, P Sonnentag, TM Nork… - Human Gene therapy …, 2016 - europepmc.org
Abstract Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1. 7-
hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human …

Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1. 7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia

G Ye, E Budzynski, P Sonnentag… - Human gene …, 2016 - pubmed.ncbi.nlm.nih.gov
Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1. 7-
hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human …

Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1. 7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia

GJ Ye, E Budzynski, P Sonnentag, TM Nork, PE Miller… - 2016 - hero.epa.gov
Abstract Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1. 7-
hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human …
[HTML] nih.gov

[HTML][HTML] Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1. 7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia

G Ye, E Budzynski, P Sonnentag, TM Nork… - Human Gene …, 2016 - ncbi.nlm.nih.gov
Abstract Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1. 7-
hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human …